{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T14:27:46Z","timestamp":1792852066194,"version":"4.5.0"},"reference-count":87,"publisher":"Oxford University Press (OUP)","issue":"special_issue_2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BJR"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1259\/bjr\/97295129","type":"journal-article","created":{"date-parts":[[2008,4,29]],"date-time":"2008-04-29T16:50:01Z","timestamp":1209487801000},"page":"S160-S167","source":"Crossref","is-referenced-by-count":200,"title":["Positron emission tomography imaging in dementia"],"prefix":"10.1093","volume":"80","author":[{"given":"K","family":"HERHOLZ","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S F","family":"CARTER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"JONES","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"R2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1977.tb03919.x"},{"key":"R3","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.1982.15"},{"key":"R4","doi-asserted-by":"publisher","DOI":"10.1007\/BF02988444"},{"key":"R5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2007.01.019"},{"key":"R6","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410420114"},{"key":"R7","doi-asserted-by":"publisher","DOI":"10.1038\/35094500"},{"key":"R8","doi-asserted-by":"publisher","DOI":"10.1006\/nimg.2002.1208"},{"key":"R9","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.198.3.8628880"},{"key":"R10","unstructured":"Ishii K, Willoch F, Minoshima S, Drzezga A, Ficaro EP, Cross DJ, et al. Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains.J Nucl Med2001;42:548\u201357."},{"key":"R11","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.1993.58"},{"key":"R12","unstructured":"Kippenhan JS, Barker WW, Nagel J, Grady C, Duara R. Neural-network classification of normal and Alzheimer's disease subjects using high-resolution and low-resolution PET cameras.Journal of Nuclear Medicine1994;35:7\u201315."},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1719"},{"key":"R14","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2343040197"},{"key":"R15","unstructured":"Herholz K, Schopphoff H, Schmidt M, Mielke R, Eschner W, Scheidhauer K, et al. Direct comparison of spatially normalized PET and SPECT scans in Alzheimer disease.Journal of Nuclear Medicine2002;43:21\u20136."},{"key":"R16","unstructured":"Messa C, Perani D, Lucignani G, Zenorini A, Zito G, et al. High-resolution technetium-99m-HMPAO SPECT in patients with probable Alzheimer's disease: comparison with fluorine-18-FDG PET.Journal of Nuclear Medicine1994;35:210\u201316."},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.42.4.765"},{"key":"R18","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.38.6.909"},{"key":"R19","doi-asserted-by":"crossref","unstructured":"Mielke R, Herholz K, Grond M, Kessler J, Heiss WD. Clinical deterioration in probable Alzheimer's disease correlates with progressive metabolic impairment of association areas.Dementia1994;5:36\u201341.","DOI":"10.1159\/000106692"},{"key":"R20","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1992.00530350056020"},{"key":"R21","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.36.10.1390"},{"key":"R22","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1990.00530070043010"},{"key":"R23","doi-asserted-by":"crossref","unstructured":"Heiss WD, Kessler J, Mielke R, Szelies B, Herholz K. Long-term effects of phosphatidylserine, pyritinol, and cognitive training in Alzheimer's disease. A neuropsychological, EEG, and PET investigation.Dementia1994;5:88\u201398.","DOI":"10.1159\/000106702"},{"key":"R24","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.5.738"},{"key":"R25","doi-asserted-by":"publisher","DOI":"10.1176\/appi.neuropsych.16.4.488"},{"key":"R26","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1995.03520360056039"},{"key":"R27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199603213341202"},{"key":"R28","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2635903100"},{"key":"R29","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.090106797"},{"key":"R30","unstructured":"Drzezga A, Grimmer T, Riemenschneider M, Lautenschlager N, Siebner H, Alexopoulus P, et al. Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F-FDG PET.J Nucl Med2005;46:1625\u201332."},{"key":"R31","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.62.11.1728"},{"key":"R32","unstructured":"Heiss WD, Pawlik G, Holthoff V, Kessler J, Szelies B. PET correlates of normal and impaired memory functions [Review].Cerebrovascular & Brain Metabolism Reviews1992;4:1\u201327."},{"key":"R33","doi-asserted-by":"publisher","DOI":"10.1002\/ana.10669"},{"key":"R34","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000163856.13524.08"},{"key":"R35","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.191044198"},{"key":"R36","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(05)70223-4"},{"key":"R37","doi-asserted-by":"publisher","DOI":"10.1016\/S1053-8119(03)00346-X"},{"key":"R38","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2003.10.007"},{"key":"R39","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410190112"},{"key":"R40","unstructured":"Ishii K, Sakamoto S, Sasaki M, Kitagaki H, Yamaji S, Hashimoto M, et al. Cerebral glucose metabolism in patients with frontotemporal dementia.Journal of Nuclear Medicine1998;39:1875\u20138."},{"key":"R41","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awm177"},{"key":"R42","doi-asserted-by":"publisher","DOI":"10.1002\/ana.1133"},{"key":"R43","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.55.10.1575"},{"key":"R44","doi-asserted-by":"publisher","DOI":"10.1007\/BF00308809"},{"key":"R45","doi-asserted-by":"publisher","DOI":"10.1126\/science.1566067"},{"key":"R46","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20009"},{"key":"R47","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jcbfm.9600146"},{"key":"R48","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000244749.20056.d4"},{"key":"R49","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000240117.55680.0a"},{"key":"R50","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(04)00853-1"},{"key":"R51","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awl178"},{"key":"R53","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000259035.98480.ed"},{"key":"R54","doi-asserted-by":"crossref","unstructured":"Forsberg A, Engler H, Almkvist O, Bolmquist G, Hagman G, Wall A, et al. PET imaging of amyloid deposition in patients with mild cognitive impairment.Neurobiol Aging2007 [epub ahead of print]","DOI":"10.1016\/j.neurobiolaging.2007.03.029"},{"key":"R55","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa054625"},{"key":"R56","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)05625-2"},{"key":"R57","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/123.11.2321"},{"key":"R58","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.42.2.447"},{"key":"R59","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)05625-2"},{"key":"R60","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20332"},{"key":"R61","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000222734.56412.17"},{"key":"R62","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.4236-05.2006"},{"key":"R63","doi-asserted-by":"crossref","unstructured":"Braak H, Rub U, Schultz C, Del Tredici K. Vulnerability of cortical neurons to Alzheimer's and Parkinson's diseases.J Alzheimers Dis2006;9:35\u201344.","DOI":"10.3233\/JAD-2006-9S305"},{"key":"R64","doi-asserted-by":"publisher","DOI":"10.1097\/00002093-199505000-00006"},{"key":"R65","doi-asserted-by":"crossref","unstructured":"Bottlaender M, Valette H, Roumenov D, Dolle F, Coulon C, Ottaviani M, et al. Biodistribution and radiation dosimetry of (18)f-fluoro-a-85380 in healthy volunteers.Journal of Nuclear Medicine2003;44:596\u2013601.","DOI":"10.1002\/syn.10047"},{"key":"R66","unstructured":"Mamede M, Ishizu K, Ueda M, Mukai T, Iida Y, Fukuyama H, et al. Quantification of human nicotinic acetylcholine receptors with 123I-5IA SPECT.Journal of Nuclear Medicine2004;45:1458\u201370."},{"key":"R67","doi-asserted-by":"publisher","DOI":"10.1097\/00002093-199505000-00006"},{"key":"R68","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-006-0447-7"},{"key":"R70","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(94)91507-5"},{"key":"R71","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2396(199602)22:2<123::AID-SYN5>3.0.CO;2-F"},{"key":"R72","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.52.4.691"},{"key":"R73","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)09124-6"},{"key":"R74","doi-asserted-by":"publisher","DOI":"10.1007\/s007020070009"},{"key":"R75","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.74.1.113"},{"key":"R76","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2004.038729"},{"key":"R77","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200212000-00012"},{"key":"R78","doi-asserted-by":"crossref","unstructured":"Kadir A, Darreh-Shori T, Almkvist O, Wall A, Grut M, Strandberg B, et al. PET imaging of the in vivo brain acetylcholinesterase activity and nicotine binding in galantamine-treated patients with AD.Neurobiol Aging2007 [epub ahead of print]","DOI":"10.1016\/j.neurobiolaging.2007.02.020"},{"key":"R79","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1992.tb10978.x"},{"key":"R80","doi-asserted-by":"crossref","unstructured":"Meltzer CC, Price JC, Mathis CA, Greer PJ, Cantwell MN, Houck PR, et al. PET imaging of serotonin type 2A receptors in late-life neuropsychiatric disorders.Am J Psychiatry1999;156:1871\u20138.","DOI":"10.1176\/ajp.156.12.1871"},{"key":"R81","doi-asserted-by":"crossref","unstructured":"Hasselbalch SG, Madsen K, Svarer C, Pinborg LH, Holm S, Paulson OB, et al. Reduced 5-HT(2A) receptor binding in patients with mild cognitive impairment.Neurobiol Aging2007 [epub ahead of print]","DOI":"10.1016\/j.neurobiolaging.2007.04.011"},{"key":"R82","doi-asserted-by":"publisher","DOI":"10.1097\/00019052-199708000-00008"},{"key":"R83","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000191154.78131.f6"},{"key":"R84","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.1993.39"},{"key":"R85","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-7634(02)00065-9"},{"key":"R86","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-004-1830-x"},{"key":"R86A","doi-asserted-by":"publisher","DOI":"10.1159\/000017196"},{"key":"R86B","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3956(98)90048-6"},{"key":"R86C","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-200103260-00045"},{"key":"R86D","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000055847.17752.E6"}],"container-title":["The British Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.birpublications.org\/doi\/pdf\/10.1259\/bjr\/97295129","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T16:21:11Z","timestamp":1705076471000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjr\/article\/80\/special_issue_2\/S160-S167\/7457161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":87,"journal-issue":{"issue":"special_issue_2","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["10.1259\/bjr\/97295129"],"URL":"https:\/\/doi.org\/10.1259\/bjr\/97295129","relation":{},"ISSN":["0007-1285","1748-880X"],"issn-type":[{"value":"0007-1285","type":"print"},{"value":"1748-880X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}